Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:1447

Free Article
This Article
Free upon publication Free Article
Right arrow Extract
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles

(Circulation. 2006;114:1447.)
© 2006 American Heart Association, Inc.

Issue Highlights


*    RANDOMIZED TRIAL OF ATORVASTATIN FOR REDUCTION OF POSTOPERATIVE ATRIAL FIBRILLATION IN PATIENTS UNDERGOING CARDIAC SURGERY: RESULTS OF THE ARMYDA-3 (ATORVASTATIN FOR REDUCTION OF MYOCARDIAL DYSRHYTHMIA AFTER CARDIAC SURGERY) STUDY, by Patti et al.
up arrowTop
*RANDOMIZED TRIAL OF ATORVASTATIN...
down arrowRELATIONSHIP BETWEEN...
down arrowEXERCISE AND RESPIRATORY...
down arrowImages in Cardiovascular...
down arrowBook Review
down arrowCorrespondence
 
Atrial fibrillation after cardiac surgery is associated with increased length of hospital stay and increased morbidity. Increasing evidence points to a role for inflammation in the pathogenesis of atrial fibrillation. In this issue of Circulation, Patti and colleagues evaluate the effect of atorvastatin on postoperative atrial fibrillation in a randomized, placebo-controlled trial of 200 patients undergoing cardiopulmonary bypass surgery. Atorvastatin begun preoperatively reduced atrial fibrillation and was associated with a small reduction in length of hospital stay. Benefit was seen in patients taking ß-adrenergic blockers and was not influenced by age. No benefit was demonstrated for the small subgroup having valve surgery. The present study is unlikely to be repeated in patients with coronary disease, as most have an indication for therapy with a 3-hydroxy-3-methylglutaryl coenzyme reductase inhibitor. It should, however, foster further studies of the mechanism of benefit and should help to determine whether patients having valve surgery alone might benefit. See p 1455.


*    RELATIONSHIP BETWEEN POSTOPERATIVE CARDIAC TROPONIN I LEVELS AND OUTCOME OF CARDIAC SURGERY, by Croal et al.
up arrowTop
up arrowRANDOMIZED TRIAL OF ATORVASTATIN...
*RELATIONSHIP BETWEEN...
down arrowEXERCISE AND RESPIRATORY...
down arrowImages in Cardiovascular...
down arrowBook Review
down arrowCorrespondence
 
Prior studies of the prognostic utility of cardiac troponin levels following cardiac surgery have been relatively small with limited duration of follow-up. Several have shown cardiac troponins to be significant independent predictors of in-hospital mortality and complications. The current findings by Croal et al are comparable with prior data relating creatine kinase-MB isoenzyme and/or troponin levels following cardiac surgery to subsequent mortality. The present study has extended these observations by reporting the prognostic utility of cardiac troponin I in a large cohort with longer follow-up. In addition, the size of the cohort allowed adjustment for potential confounding factors inherent in this patient cohort, in particular the nature of the surgery performed. The current data suggest that troponin levels following cardiac surgery could be used to identify patients who are at considerably increased risk. Cardiac troponin I levels in the highest quartile at 24 hours were independent predictors of short, medium, and long-term risks for adverse outcomes. The authors concluded that routine measurement of troponin levels after cardiac surgery may be clinically useful, and they identified a group of patients at increased risk of death. These individuals might benefit from more intensive investigation and treatment, though this remains to be tested. See p 1468.


*    EXERCISE AND RESPIRATORY TRAINING IMPROVE EXERCISE CAPACITY AND QUALITY OF LIFE IN PATIENTS WITH SEVERE CHRONIC PULMONARY HYPERTENSION, by Mereles et al.
up arrowTop
up arrowRANDOMIZED TRIAL OF ATORVASTATIN...
up arrowRELATIONSHIP BETWEEN...
*EXERCISE AND RESPIRATORY...
down arrowImages in Cardiovascular...
down arrowBook Review
down arrowCorrespondence
 
Exercise training is an effective and safe method to improve functional capacity among patients with coronary artery disease, heart failure, and peripheral arterial disease. Whether the same is true in patients with pulmonary hypertension has not been previously studied. As such, patients often have limited exercise tolerance. In this issue of Circulation, Mereles et al report the results of their seminal study in which 30 patients with pulmonary hypertension (mean pulmonary artery pressure of 50±15 mmHg) were randomized to exercise and respiratory training versus control. Changes in peak oxygen uptake, 6-minute walking distance, Borg scale, WHO functional class, quality of life, and echocardiographic parameters were assessed. The remarkable results of this study have important implications for the treatment of patients with pulmonary hypertension and serve to inspire future studies in this area. These issues are further discussed in an accompanying editorial by John Newman. See p 1482 (editorial on p 1448).

Visit http://circ.ahajournals.org:


*    Images in Cardiovascular Medicine
up arrowTop
up arrowRANDOMIZED TRIAL OF ATORVASTATIN...
up arrowRELATIONSHIP BETWEEN...
up arrowEXERCISE AND RESPIRATORY...
*Images in Cardiovascular...
down arrowBook Review
down arrowCorrespondence
 
Sixty-Four–Multislice Computed Tomography Image of a Ruptured Coronary Plaque. See p e519.


Figure 14166
View larger version (50K):
[in this window]
[in a new window]
 

Therapeutic Hypothermia–Related Torsade de Pointes. See p e521.

Rapid Resolution of Massive Lung Abscesses Complicating Tricuspid Valve Endocarditis. See p e523.


*    Book Review
up arrowTop
up arrowRANDOMIZED TRIAL OF ATORVASTATIN...
up arrowRELATIONSHIP BETWEEN...
up arrowEXERCISE AND RESPIRATORY...
up arrowImages in Cardiovascular...
*Book Review
down arrowCorrespondence
 
Macro- and Micro Circulation in Hypertension. See p e525.


*    Correspondence
up arrowTop
up arrowRANDOMIZED TRIAL OF ATORVASTATIN...
up arrowRELATIONSHIP BETWEEN...
up arrowEXERCISE AND RESPIRATORY...
up arrowImages in Cardiovascular...
up arrowBook Review
*Correspondence
 
See p e526.


Related Articles:

Exercise Training in Pulmonary Hypertension: Implications for the Evaluation of Drug Trials
John H. Newman and Ivan M. Robbins
Circulation 2006 114: 1448-1449. [Extract] [Full Text]

Sixty-Four–Multislice Computed Tomography Image of a Ruptured Coronary Plaque
Nobuyoshi Tanaka, Mariko Ehara, Jean-François Surmely, Tetsuo Matsubara, Mitsuyasu Terashima, Etsuo Tsuchikane, Osamu Katoh, and Takahiko Suzuki
Circulation 2006 114: e519-e520. [Extract] [Full Text]

Therapeutic Hypothermia-Related Torsade de Pointes
Chien-Hua Huang, Min-Shan Tsai, Chiung-Yuan Hsu, and Wen-Jone Chen
Circulation 2006 114: e521-e522. [Extract] [Full Text]

Rapid Resolution of Massive Lung Abscesses Complicating Tricuspid-Valve Endocarditis
Yok-Ai Que, Olivier Muller, and Lucas Liaudet
Circulation 2006 114: e523-e524. [Extract] [Full Text]

Macro- and Micro Circulation in Hypertension
Michael O’Rourke
Circulation 2006 114: e525. [Extract] [Full Text]

Letter by Schinkel et al Regarding Article, "Projected Valve Area at Normal Flow Rate Improves the Assessment of Stenosis Severity in Patients With Low-Flow, Low-Gradient Aortic Stenosis: The Multicenter TOPAS (Truly or Pseudo-Severe Aortic Stenosis) Study"
Arend F.L. Schinkel, Manolis Bountioukos, Don Poldermans, and Jeroen J. Bax
Circulation 2006 114: e526. [Extract] [Full Text]

Relationship Between Postoperative Cardiac Troponin I Levels and Outcome of Cardiac Surgery
Bernard L. Croal, Graham S. Hillis, Patrick H. Gibson, Mohammed T. Fazal, Hussein El-Shafei, George Gibson, Robert R. Jeffrey, Keith G. Buchan, Douglas West, and Brian H. Cuthbertson
Circulation 2006 114: 1468-1475. [Abstract] [Full Text]

Randomized Trial of Atorvastatin for Reduction of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) Study
Giuseppe Patti, Massimo Chello, Dario Candura, Vincenzo Pasceri, Andrea D’Ambrosio, Elvio Covino, and Germano Di Sciascio
Circulation 2006 114: 1455-1461. [Abstract] [Full Text]




This Article
Free upon publication Free Article
Right arrow Extract
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles